Plerixa 24 (Plerixafor Vials) 24mg/1.2ml

Plerixa 24 is an injectable pharmaceutical containing plerixafor, used to support stem cell mobilization. This 24mg/1.2ml vial is designed for subcutaneous administration in clinical settings. Ideal for patients requiring stem cell collection for transplants. Store between 15-25°C.

Strength

24mg/1.2ml

Pack Size

Storage

15-25°

Manufacturer / TM Owner

TherDose Pharma Pvt Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Plerixafor is commonly used to help mobilize stem cells from the bone marrow into the bloodstream. This process makes it easier to collect stem cells for procedures like bone marrow transplants. It is often prescribed when standard mobilization methods are insufficient. The medication works by blocking certain receptors to release stem cells.

Side Effects

After administration, plerixafor typically begins working within a few hours to increase stem cell counts in the blood. Patients may experience mild injection site reactions like redness or swelling. Some individuals report temporary fatigue or nausea following treatment. These effects are generally short-lived and resolve without intervention.

Precautions & Warnings

Plerixa 24 should only be handled and administered by trained healthcare professionals. Patients with known allergies to plerixafor or its components should avoid this medication. Keep the vial refrigerated until use and protect it from light. Dispose of used vials and needles properly according to medical waste guidelines.

Avoid Interactions

Plerixafor may interact with other medications that affect the immune system or blood cell counts. Combining it with certain chemotherapy drugs could alter effectiveness or side effects. Always inform your healthcare provider about all medications being taken. No specific dietary restrictions are required while using this medication.

References

Frequently Asked Questions

Plerixafor is used to help mobilize stem cells from the bone marrow into the bloodstream for collection and transplant procedures.

Plerixa 24 is administered as a subcutaneous injection by a healthcare professional.

Common effects may include injection site reactions, fatigue, or nausea.

Plerixafor is a prescription medication and should only be obtained through licensed pharmacies or healthcare providers.

Store Plerixa 24 vials between 15-25°C and protect from light until use.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.